Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Considerations, challenges and future of anti-TNF therapy in treating inflammatory bowel disease

Published:2016-07-04 Issue:10 Volume:16 Page:1277-1290
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Pouillon Lieven¹,Bossuyt Peter²,Peyrin-Biroulet Laurent³

Affiliation:

1. Department of Hepato-Gastroenterology, University Hospitals Leuven, Uz Gasthuisberg, Leuven, Belgium

2. Imelda GI Clinical Research Centre, Imeldaziekenhuis Bonheiden, Bonheiden, Belgium

3. Inserm U954 and Department of Gastroenterology, Nancy University Hospital, Université de Lorraine, Vandœuvre-lès-Nancy, France

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2016.1203897

Reference146 articles.

1. Crohn's disease

2. Ulcerative colitis

3. Crohn's disease: beyond antagonists of tumour necrosis factor

4. Tumour-necrosis-factor antibody treatment in Crohn's disease

5. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to Upadacitinib in Patients with Inflammatory Bowel Disease Previously Treated with Tofacitinib;Digestive Diseases and Sciences;2024-09-09

2. Unlocking the Potential of Extracellular Vesicles as the Next Generation Therapy: Challenges and Opportunities;Tissue Engineering and Regenerative Medicine;2024-04-10

3. Therapeutic Applications of Extracellular Vesicles in Inflammatory Bowel Disease;International Journal of Molecular Sciences;2024-01-06

4. Network Meta-analysis of efficacy and safety of drugs for the treatment of moderate to severe ulcerative colitis;2023-11-15

5. Potential protective effects of the water-soluble Chinese propolis on experimental ulcerative colitis;J TRADIT CHIN MED;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3